NCT05612776

Brief Summary

Consequences of stroke are manyfold but all of them are important factors on the long-term outcomes of rehabilitation, becoming an important health problem with requires health strategies with advanced age. High intensity interval training (HIIT) is an efficient training protocol used in cardiac rehabilitation programs, but owing to the inter-individual variability in physiological responses to training associated to cardiovascular diseases, the exercise dose received by each patient should be closely controlled and individualized to ensure the safety and efficiency of the exercise program. The heart rate variability (HRV) is actually being used for this purpose, as it is closely linked to de parasympathetic nervous system activation. In this way, higher scores in HRV are associated with a good cardiovascular adaptation. The objective of this protocol is to determine the effect of HIIT compared with HRV-guided training on cardiorespiratory fitness, heart rate variability, functional parameters, body composition, quality of life, inflammatory markers, cognitive function, and feasibility, safety and adherence in patients after stroke undertaking an 8-week cardiac rehabilitation program. This will be a cluster-randomized controlled protocol in which patients after stroke will be assigned to an HRV-based training group (HRV-G) or a HIIT-based training group (HIIT-G). HIIT-G will train according to a predefined training program. HRV-G training will depend on the patients' daily HRV. The peak oxygen uptake (VO2peak), endothelial and work parameters, the heart rate variability, the functional parameters, the relative weight and body fat distribution, the quality of life, the inflammatory markers, the cognitive function, and the exercise adherence, feasibility and safety will be considered as the outcomes. It is expected that this HRV-guided training protocol will improve functional performance in the patients after stroke, being more safe, feasible and generating more adherence than HIIT, providing a better strategy to optimize the cardiac rehabilitation interventions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 10, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

November 10, 2022

Status Verified

November 1, 2022

Enrollment Period

8 months

First QC Date

July 19, 2022

Last Update Submit

November 4, 2022

Conditions

Keywords

Heart Rate VariabilityHIITcardiac rehabilitationsafetyadherenceVO2peak

Outcome Measures

Primary Outcomes (1)

  • Peak oxygen uptake (VO2peak) changes

    According to the Spanish Society of Cardiology, the modified Bruce procotol will be used as a treadmill test, as it is indicated for people considered to be at high risk and the elderly.

    baseline and week 8

Secondary Outcomes (13)

  • Heart rate variability

    every day before starting the intervention

  • Functional performance

    Baseline and week 8

  • Body mass index (BMI)

    Baseline and week 8

  • Quality of life MacNew

    Baseline and week 8

  • Number of participants with abnormal laboratory test results

    baseline and week 8

  • +8 more secondary outcomes

Study Arms (2)

HIIT-based training

EXPERIMENTAL

The HIIT group will train according to a predefined high intensity training program

Other: HIIT

HRV-based training

EXPERIMENTAL

The training prescribed to the HRV group will depend on the subjects' diary HRV

Other: HRV

Interventions

HIITOTHER

HIIT training will consist of performing high intensity intervals along with passive rests. The intensity of the exercise will be progressively increased and the rest time will be decreased. All participants will perform the same training according to the maximum heart rate reached in the Bruce test.

HIIT-based training
HRVOTHER

The intervention group will perform HRV-based training, measuring HRV every day before training in order to obtain HRV normality ranges for each participant. If the HRV value is within the normal range, the participant will perform a high intensity training but if the HRV value is below the normal range, the participant will perform a continuous training at low intensity as active rest.

HRV-based training

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • left ejection fraction higher than 30% after stroke
  • aged between 18 and 80 years old

You may not qualify if:

  • presence of absolute or relative contraindications for accomplishing the treadmill test, indicated by the Spanish Society of Cardiology
  • being treated for other diseases, or regularly taking a drug(s) that has a direct or indirect effect on the nervous system (e.g., anxiolytics, antidepressants or neuroleptics)
  • absence of medication to control the cardiovascular disease or its modification during the intervention
  • people who are participating or have participated in the previous three months in other similar exercise programs
  • not performing at least 80% of the workouts during the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CITE III

Almería, 04120, Spain

RECRUITING

MeSH Terms

Conditions

StrokeHeart DiseasesIschemic StrokeMyocardial Ischemia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

María Carrasco, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 19, 2022

First Posted

November 10, 2022

Study Start

December 1, 2022

Primary Completion

August 1, 2023

Study Completion

December 1, 2023

Last Updated

November 10, 2022

Record last verified: 2022-11

Locations